[1] KIRSCH C, ECKERT G P, KOUDINOV A R, et al. Brain Cholesterol, Statins and Alzheimer's Disease[J]. Pharmacopsychiatry, 2003(36): 113-119.
[2] LU Dunyue, GOUSSEV A, CHEN Jieli, et al. Atorvastatin Reduces Neurological Deficit and Increases Synaptogenesis, Angiogenesis, and Neuronal Survival in Rats Subjected to Traumatic Brain Injury [J]. Journal of Neurotrauma, 2004, 21(1): 21-32.
[3] KONG Fanqi, YE Bozhi, LIN Lu, et al. Atorvastatin Suppresses NLRP3 Inflammasome Activation Via TLR4/MyD88/NF-κB Signaling in PMA-Stimulated THP-1 Monocytes[J]. Biomedicine & pharmacotherapy, 2016, 82: 167-172.
[4] VOLLMER T, KEY L, DURKALSKI V, et al. Oral Simvastatin Treatment in Relapsing-Remitting Multiple Sclerosis[J]. The Lancet, 2004, 363(9421): 1607-1608.
[5] RAVIZZA T, VEZZANI A. Status Epilepticus Induces Time-Dependent Neuronal and Astrocytic Expression of Interleukin-1 Receptor Type I in the Rat Limbic System[J]. Neuroscience, 2006, 137(1): 301-308.
[6] ARGANARAZ G A, PEROSA S R, LENCIONI E C, et al. Role of Kinin B1 and B2 Receptors in the Development of Pilocarpine Model of Epilepsy[J]. Brain Research, 2004, 1013(1): 30-39.
[7] GOUVEIA T L F, SCORZA F A, SILVA M J V, et al. Lovastatin Decreases the Synthesis of Inflammatory Mediators in the Hippocampus and Blocks the Hyperthermia of Rats Submitted to Long-Lasting Status Epilepticus[J]. Epilepsy & Behavior, 2011, 20(1): 1-5.
[8] RACINE R J. Modification of Seizure Activity by Electrical Stimulation: II. Motor Seizure[J]. Electroencephalography and Clinical Neurophysiology, 1972, 32(3): 281-294.
[9] 吴海洋,贺振华,张新定.炎症因子在癫痫中的作用研究进展[J].军事医学,2018,42(10):796-800.
[10] WANG Haichen, LYNCH J R, SONG Pingping, et al. Simvastatin and Atorvastatin Improve Behavioral Outcome, Reduce Hippocampal Degeneration, and Improve Cerebral Blood Flow After Experimental Traumatic Brain Injury[J]. Experimental Neurology, 2007, 206(1): 59-69.
[11] CITRARO R, CHIMIRRI S, AIELLO R, et al. Protective Effects of Some Statins on Epileptogenesis and Depressive-Like Behavior in WAG/Rij Rats, a Genetic Animal Model of Absence Epilepsy[J]. Epilepsia, 2014, 55(8): 1284-1291.
[12] PONCE J, DE LA OSSA N P, HURTADO O, et al. Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts: A Cholesterol-Mediated Effect in Neuroprotection[J]. Stroke, 2008, 39(4): 1269-1275.
[13] XIE Chuncheng, SUN Jiahang, QIAO Weidong, et al. Administration of Simvastatin after Kainic Acid-Induced Status Epilepticus Restrains Chronic Temporal Lobe Epilepsy [J]. PLoS One, 2011, 6(9): e24966.
[14] GOUVEIA T L F, SCORZA F A, IHA H A, et al. Lovastatin Decreases the Synthesis of Inflammatory Mediators During Epileptogenesis in the Hippocampus of Rats Submitted to Pilocarpine-Induced Epilepsy[J]. Epilepsy & Behavior, 2014, 36: 68-73.
[15] WANG Yan, QIN Zhenghong. Molecular and Cellular Mechanisms of Excitotoxic Neuronal Death[J]. Apoptosis, 2010, 15(11): 1382-1402.
[16] LEE S T, CHU K, PARK J E, et al. Atorvastatin Attenuates Mitochondrial Toxin-Induced Striatal Degeneration, with Decreasing iNOS/c-Jun Levels and Activating ERK/Akt Pathways[J]. Journal of Neurochemistry, 2008, 104(5):1190-1200.
|